Profit with us in the 2009 bear market
   

Mark D. Erion Ph.D.

Rate this Executive:
Not rated yet Not rated yet.
This is a page dedicated to get more information for investors to evaluate the management style of Mark D. Erion Ph.D. who is a Co-Founder of Metabasis Therapeutics, Inc.

Here on this page we are inviting all readers to discuss Mark D. Erion Ph.D.. You may anonymously post comments with any information that they have about Mark D. Erion Ph.D.. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

User comments


Type the characters that you see in the box (5 characters).

This is a captcha-picture. It is used to prevent mass-access by robots. (see: www.captcha.net)

  
I would like to be notified by e-mail if someone comments on this page. Email confirmation needed. Privacy Statement.
   
   
Here is a copy of personal Bio that we found:
Name: Mark D. Erion Ph.D.
Age: 51
« Michael Ferverda Mitchell W. Kitayama »
   
   
Company name Officer position Pay Exercised
Metabasis Therapeutics, Inc Co-Founder, Chief Scientific Officer, Exec. VP of R&D $ 358.00K $ 0
   
   
   
   
   

Add to Google
Add to My Yahoo!
Feedburner
rss
rss Full-text
 
 
Home > Officers > Mark D. Erion Ph.D.
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.